EXICURE, INC. Increase (Decrease) in Other Noncurrent Assets
EXICURE, INC. (XCUR) reported Increase (Decrease) in Other Noncurrent Assets of $0 for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherNoncurrentAssets · last filed 2026-08-14
- EXICURE, INC. increase (decrease) in other noncurrent assets for the quarter ending 2025-12-31 was -$853.00K.
- EXICURE, INC. increase (decrease) in other noncurrent assets for the quarter ending 2025-09-30 was -$79.00K.
- EXICURE, INC. increase (decrease) in other noncurrent assets for the quarter ending 2024-12-31 was $0.00, a 100.00% decline year-over-year.
- EXICURE, INC. increase (decrease) in other noncurrent assets for the quarter ending 2024-09-30 was $0.00.
- EXICURE, INC. increase (decrease) in other noncurrent assets for fiscal 2025 was -$198.00K.
- EXICURE, INC. increase (decrease) in other noncurrent assets for fiscal 2024 was $0.00.
- EXICURE, INC. increase (decrease) in other noncurrent assets for fiscal 2023 was -$38.00K, a 101.76% decline from fiscal 2022.
- EXICURE, INC. increase (decrease) in other noncurrent assets for fiscal 2022 was $2.17M.
| Period end | Increase (Decrease) in Other Noncurrent Assets 3 month | Increase (Decrease) in Other Noncurrent Assets 6 month | Increase (Decrease) in Other Noncurrent Assets 9 month | Increase (Decrease) in Other Noncurrent Assets 12 month |
|---|---|---|---|---|
| 2026-06-30 | $0.00 10-Q · filed 2026-08-14 | |||
| 2025-12-31 | -$853.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | -$932.00K derived: sum of 2 quarters · filed 2026-03-25 | -$198.00K 10-K · filed 2026-03-25 | |
| 2025-09-30 | -$79.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | $655.00K 10-Q · filed 2025-11-07 | ||
| 2025-06-30 | $734.00K 10-Q · filed 2026-08-14 | |||
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | $0.00 derived: sum of 2 quarters · filed 2026-03-25 | $0.00 derived: sum of 3 quarters · filed 2026-03-25 | $0.00 10-K · filed 2026-03-25 |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | $0.00 derived: sum of 2 quarters · filed 2025-11-07 | $0.00 10-Q · filed 2025-11-07 | $253.00K derived: sum of 4 quarters · filed 2025-11-07 |
| 2024-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-08 | $0.00 10-Q · filed 2025-08-08 | $253.00K derived: sum of 3 quarters · filed 2025-08-08 | $250.00K derived: sum of 4 quarters · filed 2025-08-08 |
| 2024-03-31 | $0.00 10-Q · filed 2024-06-17 | $253.00K derived: sum of 2 quarters · filed 2025-03-18 | $250.00K derived: sum of 3 quarters · filed 2025-03-18 | $142.00K derived: sum of 4 quarters · filed 2025-03-18 |
| 2023-12-31 | $253.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-18 | $250.00K derived: sum of 2 quarters · filed 2025-03-18 | $142.00K derived: sum of 3 quarters · filed 2025-03-18 | -$38.00K 10-K · filed 2025-03-18 |
| 2023-09-30 | -$3.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | -$111.00K derived: sum of 2 quarters · filed 2024-11-14 | -$291.00K 10-Q · filed 2024-11-14 | $1.92M derived: sum of 4 quarters · filed 2024-11-14 |
| 2023-06-30 | -$108.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-13 | -$288.00K 10-Q · filed 2024-08-13 | $1.93M derived: sum of 3 quarters · filed 2024-08-13 | $1.90M derived: sum of 4 quarters · filed 2024-08-13 |
| 2023-03-31 | -$180.00K 10-Q · filed 2024-06-17 | $2.03M derived: sum of 2 quarters · filed 2024-06-17 | $2.01M derived: sum of 3 quarters · filed 2024-06-17 | $1.99M derived: sum of 4 quarters · filed 2024-06-17 |
| 2022-12-31 | $2.21M derived: 10-K 12 month − 10-Q 9 month · filed 2024-06-06 | $2.19M derived: sum of 2 quarters · filed 2024-06-06 | $2.17M derived: sum of 3 quarters · filed 2024-06-06 | $2.17M 10-K · filed 2024-06-06 |
| 2022-09-30 | -$24.00K derived: 10-Q 9 month − 10-Q/A 6 month · filed 2024-05-16 | -$44.00K derived: sum of 2 quarters · filed 2024-06-06 | -$48.00K 10-Q · filed 2024-05-16 | -$188.00K derived: sum of 4 quarters · filed 2024-06-06 |
| 2022-06-30 | -$20.00K derived: 10-Q/A 6 month − 10-Q/A 3 month · filed 2024-06-06 | -$24.00K 10-Q/A · filed 2024-06-06 | -$164.00K derived: sum of 3 quarters · filed 2024-06-06 | -$136.00K derived: sum of 4 quarters · filed 2024-06-06 |
| 2022-03-31 | -$4.00K 10-Q/A · filed 2024-06-06 | -$144.00K derived: sum of 2 quarters · filed 2024-06-06 | -$116.00K derived: sum of 3 quarters · filed 2024-06-06 | -$105.00K derived: sum of 4 quarters · filed 2024-06-06 |
| 2021-12-31 | -$140.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-27 | -$112.00K derived: sum of 2 quarters · filed 2023-03-27 | -$101.00K derived: sum of 3 quarters · filed 2023-03-27 | -$68.00K 10-K · filed 2023-03-27 |
| 2021-09-30 | $28.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $39.00K derived: sum of 2 quarters · filed 2022-11-14 | $72.00K 10-Q · filed 2022-11-14 | $52.00K derived: sum of 4 quarters · filed 2022-11-14 |
| 2021-06-30 | $11.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-15 | $44.00K 10-Q · filed 2022-08-15 | $24.00K derived: sum of 3 quarters · filed 2022-08-15 | -$829.00K derived: sum of 4 quarters · filed 2022-08-15 |
| 2021-03-31 | $33.00K 10-Q · filed 2022-05-16 | $13.00K derived: sum of 2 quarters · filed 2022-05-16 | -$840.00K derived: sum of 3 quarters · filed 2022-05-16 | $224.00K derived: sum of 4 quarters · filed 2022-05-16 |
| 2020-12-31 | -$20.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-25 | -$873.00K derived: sum of 2 quarters · filed 2022-03-25 | $191.00K derived: sum of 3 quarters · filed 2022-03-25 | $161.00K 10-K · filed 2022-03-25 |
| 2020-09-30 | -$853.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-19 | $211.00K derived: sum of 2 quarters · filed 2021-11-19 | $181.00K 10-Q · filed 2021-11-19 | $181.00K derived: sum of 4 quarters · filed 2021-11-19 |
| 2020-06-30 | $1.06M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12 | $1.03M 10-Q · filed 2021-08-12 | $1.03M derived: sum of 3 quarters · filed 2021-08-12 | $1.15M derived: sum of 4 quarters · filed 2021-08-12 |
| 2020-03-31 | -$30.00K 10-Q · filed 2021-05-12 | -$30.00K derived: sum of 2 quarters · filed 2021-05-12 | $82.00K derived: sum of 3 quarters · filed 2021-05-12 | -$589.00K derived: sum of 4 quarters · filed 2021-05-12 |
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-11 | $112.00K derived: sum of 2 quarters · filed 2021-03-11 | -$559.00K derived: sum of 3 quarters · filed 2021-03-11 | $0.00 10-K · filed 2021-03-11 |
| 2019-09-30 | $112.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-12 | -$559.00K derived: sum of 2 quarters · filed 2020-11-12 | $0.00 10-Q · filed 2020-11-12 | |
| 2019-06-30 | -$671.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-12 | -$112.00K 10-Q · filed 2020-08-12 | ||
| 2019-03-31 | $559.00K 10-Q · filed 2020-05-14 | |||
| 2018-06-30 | $32.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-08 | $32.00K 10-Q · filed 2019-08-08 | ||
| 2018-03-31 | $0.00 10-Q · filed 2019-05-08 | |||
| 2017-06-30 | $12.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-06 | $31.00K 10-Q · filed 2018-08-06 | ||
| 2017-03-31 | $19.00K 10-Q · filed 2018-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SOLIGENIX, INC. (SNGX) | United States | $0.008B | |
| Imunon, Inc. (IMNN) | United States | $0.008B | -0.56 |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| Traws Pharma, Inc. (TRAW) | United States | $0.009B | -0.58 |
| Alzamend Neuro, Inc. (ALZN) | United States | $0.009B | |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| FibroBiologics, Inc. (FBLG) | United States | $0.009B | -0.27 |